It was an interesting day yesterday on Wall Street, up nicely in the morning to new all-time highs, and then rolled them over, and rolled them over hard before a late bounce. Perhaps it’s a sign that the market wants to take a rest, but we’ll just have to wait and see what happens in the next few days.
Second Sight Medical Products, (NASDAQ:EYES) has had two consecutive big days with big volume. It broke through resistance on Wednesday, up 2.70 to 13.90, or 24%, on 9.8 million shares. The next target on EYES if it gets a follow-through is 16-16 1/4-1/2. But at some point shortly it’s going to get some pullback consolidation.
FireEye, (NASDAQ:FEYE) was up 1.43 to 45.40, or 31/4%, on 15.7 million shares. This stock has had some very nice action after the run-up and break out of the base. The pullback has held some four or five days now above the 42 1/2 range. If it can get above the recent spike high at 46.18, it could see 50-51, which is the next target.
TG Therapeutics, (NASDAQ:TGTX) popped 1.51 to 15.26 or 11%, on 1.25 million shares on Wednesday. That’s the best volume in two months. The next target on this one should it extend will be up to 15 1/2, and the double-top at 18.
ZIOPHARM Oncology, (NASDAQ:ZIOP) had a run-up late in the day on Wednesday, up 60 cents to right near the high for the day at 10.50, or 6%, on 3.3 million shares. This looks like an accelerating, rising flag that could explode toward 14 1/2-15 short-term target.
Other stocks on Harry’s Charts of the Day included Advaxis, (NASDAQ:ADXS), Biocept, (NASDAQ:BIOC), BroadSoft, (NASDAQ:BSFT), EPIRUS Biopharmaceuticals, (NASDAQ:EPRS), First Solar, (NASDAQ:FSLR), Helios and Matheson Analytics (HMNY), Nuverra Environmental Solutions, (NYSE:NES), Opko Health, (OPK), Regulus Therapeutics (NASDAQ:RGLS), the Rubicon Project, (NYSE:RUBI), and Sorrento Therapeutics, (NASDAQ:SRNE)).